PRAXSYN CORPORATION Financials (USD)
| Sales 2013 | - | Sales 2014 | 66.6M | Capitalization | 21.43M |
|---|---|---|---|---|---|
| Net income 2013 | -5M | Net income 2014 | -12M | EV / Sales 2013 | - |
| Net Debt 2013 | 586K | Net Debt 2014 | 2.88M | EV / Sales 2014 | 0.36 x |
| P/E ratio 2013 |
-0.27
x | P/E ratio 2014 |
-1.14
x | Employees | - |
| Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 99.95% |
More Fundamentals
* Assessed data
More news
| Managers | Title | Age | Since |
|---|---|---|---|
Daniel Oswald
CEO | Chief Executive Officer | - | 20-01-21 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Daniel Oswald
CEO | Chief Executive Officer | - | 20-01-21 |
Praxsyn Corporation is a holding company. The Company operates through its subsidiaries, Mesa Pharmacy, Inc. (Mesa) and Nevada Health RX, Inc (NHRX). Through Mesa, the Company focuses on administration and collection of its portfolio of Workers Compensation (WC) accounts receivable. Through NHRX, the Company markets medical supplies through direct sales to medical practitioners. Through Praxsyn Capital Corporation (PraxCapita), the Company provides revenue cycle management solutions for healthcare providers focusing on Personal Injury (PI) and WC. Through Praxsyn Medical Inc., the Company is engaged in retail pharmacy and medical supplies and equipment.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +25.83% | 653B | |
| +27.00% | 556B | |
| -6.76% | 354B | |
| +20.34% | 331B | |
| +3.00% | 296B | |
| +13.09% | 233B | |
| +5.46% | 201B | |
| -9.61% | 193B | |
| -6.26% | 144B |
